HL7 v2.8.1 Vocabulary
0.2.0 - ci-build

HL7 v2.8.1 Vocabulary, published by HL7/FO. This guide is not an authorized publication; it is the continuous build for version 0.2.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/frankoemig/hl7.v2.terminology.v281/ and changes regularly. See the Directory of published versions

## CodeSystem: Manufacturers of Vaccines (code=MVX) (2.8.1 - 1.3.0) (Experimental)

Official URL: http://terminology.hl7.org/v2plusvocab/CodeSystem/PhManufacturersOfVaccinesMvxCdcNip | Version: 1.3.0
Active as of 2026-03-13 | Computable Name: PhManufacturersOfVaccinesMvxCdcNip
Other Identifiers: OID:2.16.840.1.113883.12.227, urn:ietf:rfc:3986#Uniform Resource Identifier (URI)#http://terminology.hl7.org/v2plusvocab/CodeSystem/v2-0227
Copyright/Legal: HL7 Inc., 2026

Table of codes specifying the organization that manufactures a vaccine. The values are maintained by the US Centers of Disease Control. Note that the source of truth for these code values are maintained by the CDC, and the code system may be accessed at URL: https://phinvads.cdc.gov/vads/SearchCodeSystems_search.action?searchOptions.searchText=PH_ManufacturersOfVaccinesMVX_CDC_NIP. The value set is also maintained by the CDC, and may be accessed at URL: https://phinvads.cdc.gov/vads/SearchValueSets_search.action?searchOptions.searchText=PHVS_ManufacturersOfVaccinesMVX_CDC_NIP

This Code system is referenced in the content logical definition of the following value sets:

- PhvsManufacturersOfVaccinesMvxCdcNip

Properties

This code system defines the following properties for its concepts

Name | Code | URI | Type | Description
version introduced | versionIntroduced | http://terminology.hl7.org/v2plusvocab/CodeSystem/Property#versionIntroduced | string | version when was this code introduced
version deprecated | versionDeprecated | http://terminology.hl7.org/v2plusvocab/CodeSystem/Property#versionDeprecated | string | version when was this code deprecated
status | status | http://hl7.org/fhir/concept-properties#status | code | A code that indicates the status of the concept. Typical values are active, experimental, deprecated, and retired
comment, to suppress IG-publisher warning, to be replaced with standard later | comment | http://terminology.hl7.org/v2plusvocab/CodeSystem/Property#comment | string | A string that provides additional detail pertinent to the use or understanding of the concept
usage | usage | http://terminology.hl7.org/v2plusvocab/CodeSystem/Property#usage | string | usage notes for this code
modified | modified | http://terminology.hl7.org/v2plusvocab/CodeSystem/Property#modified | dateTime | date of last modification

Concepts

This case-sensitive code system `http://terminology.hl7.org/v2plusvocab/CodeSystem/PhManufacturersOfVaccinesMvxCdcNip` defines the following codes:

Code | Display | Definition | version introduced | usage
AB | Abbott Laboratories | Abbott Laboratories | 2.3 | (includes Ross Products Division)
AD | Adams Laboratories, Inc. | Adams Laboratories, Inc. | 2.3 |
ALP | Alpha Therapeutic Corporation | Alpha Therapeutic Corporation | 2.3 |
AR | Armour | Armour | 2.3 | [Inactive--use AVB]
AVB | Aventis Behring L.L.C. | Aventis Behring L.L.C. | 2.5 | (formerly Centeon L.L.C.; includes Armour Pharmaceutical Company) [Inactive--use ZLB] CDC Changes made on: Feb. 28, 2006
AVI | Aviron | Aviron | 2.3.1 |
BA | Baxter Healthcare Corporation | Baxter Healthcare Corporation | 2.3 | [Inactive--use BAH]
BAH | Baxter Healthcare Corporation | Baxter Healthcare Corporation | 2.5 | (includes Hyland Immuno, Immuno International AG, and North American Vaccine, Inc.)
BAY | Bayer Corporation | Bayer Corporation | 2.3 | (includes Miles, Inc. and Cutter Laboratories)
BP | Berna Products | Berna Products | 2.3 | [Inactive--use BPC]
BPC | Berna Products Corporation | Berna Products Corporation | 2.3.1 | (includes Swiss Serum and Vaccine Institute Berne)
CEN | Centeon L.L.C. | Centeon L.L.C. | 2.3.1 | [Inactive--use AVB]
CHI | Chiron Corporation | Chiron Corporation | 2.3.1 | [Inactive--use NOV] includes PowderJect Pharmaceuticals, Celltech Medeva Vaccines and Evans Medical Limited CDC Changes made on: July 14, 2006
CMP | Celltech Medeva Pharmaceuticals | Celltech Medeva Pharmaceuticals | 2.5 | [Inactive--use NOV] CDC Changes made on: July 14, 2006
CNJ | Cangene Corporation | Cangene Corporation | 2.6 | CDC Changes made on: Feb. 28, 2006
CON | Connaught | Connaught | 2.3 | [Inactive--use PMC]
DVC | DynPort Vaccine Company, LLC | DynPort Vaccine Company, LLC | 2.6 | CDC Changes made on: July 14, 2006
EVN | Evans Medical Limited | Evans Medical Limited | 2.3 | [Inactive--use NOV] CDC Changes made on: July 14, 2006
GEO | GeoVax Labs, Inc. | GeoVax Labs, Inc. | 2.6 | CDC Changes made on: July 14, 2006
GRE | Greer Laboratories, Inc. | Greer Laboratories, Inc. | 2.3 |
IAG | Immuno International AG | Immuno International AG | 2.3.1 | [Inactive--use BAH]
IM | Merieux | Merieux | 2.3 | [Inactive--use PMC]
IUS | Immuno-U.S., Inc. | Immuno-U.S., Inc. | 2.3 |
JPN | The Research Foundation for Microbial Diseases of Osaka University | The Research Foundation for Microbial Diseases of Osaka University | 2.3 | (BIKEN)
KGC | Korea Green Cross Corporation | Korea Green Cross Corporation | 2.3 |
LED | Lederle | Lederle | 2.3 | [Inactive--use WAL]
MA | Massachusetts Public Health Biologic Laboratories | Massachusetts Public Health Biologic Laboratories | 2.3 | [Inactive--use MBL]
MBL | Massachusetts Biologic Laboratories | Massachusetts Biologic Laboratories | 2.5 | (formerly Massachusetts Public Health Biologic Laboratories)
MED | MedImmune, Inc. | MedImmune, Inc. | 2.3.1 |
MIL | Miles | Miles | 2.3 | [Inactive--use BAY]
MIP | Bioport Corporation | Bioport Corporation | 2.3 | (formerly Michigan Biologic Products Institute)
MSD | Merck & Co., Inc. | Merck & Co., Inc. | 2.3 |
NAB | NABI | NABI | 2.3 | (formerly North American Biologicals, Inc.)
NAV | North American Vaccine, Inc. | North American Vaccine, Inc. | 2.3.1 | [Inactive--use BAH]
NOV | Novartis Pharmaceutical Corporation | Novartis Pharmaceutical Corporation | 2.3.1 | (includes Chiron, PowderJect Pharmaceuticals, Celltech Medeva Vaccines and Evans Limited, Ciba-Geigy Limited and Sandoz Limited)
NVX | Novavax, Inc. | Novavax, Inc. | 2.6 | CDC Changes made on: July 14, 2006
NYB | New York Blood Center | New York Blood Center | 2.3 |
ORT | Ortho-Clinical Diagnostics | Ortho-Clinical Diagnostics | 2.3.1 | (formerly Ortho Diagnostic Systems, Inc.)
OTC | Organon Teknika Corporation | Organon Teknika Corporation | 2.3 |
OTH | Other manufacturer | Other manufacturer | 2.3 |
PD | Parkedale Pharmaceuticals | Parkedale Pharmaceuticals | 2.3 | (formerly Parke-Davis)
PMC | sanofi pasteur | sanofi pasteur | 2.3.1 | (formerly Aventis Pasteur, Pasteur Merieux Connaught; includes Connaught Laboratories and Pasteur Merieux) CDC Changes made on: Feb. 28, 2006
PRX | Praxis Biologics | Praxis Biologics | 2.3 | [Inactive--use WAL]
PWJ | PowderJect Pharmaceuticals | PowderJect Pharmaceuticals | 2.5 | (includes Celltech Medeva Vaccines and Evans Medical Limited) [Inactive--use NOV] CDC Changes made on: July 14, 2006
SCL | Sclavo, Inc. | Sclavo, Inc. | 2.3 |
SI | Swiss Serum and Vaccine Inst. | Swiss Serum and Vaccine Inst. | 2.3 | [Inactive--use BPC]
SKB | GlaxoSmithKline | GlaxoSmithKline | 2.3 | (formerly SmithKline Beecham; includes SmithKline Beecham and Glaxo Welcome)
SOL | Solvay Pharmaceuticals | Solvay Pharmaceuticals | 2.6 | CDC Changes made on: July 14, 2006
TAL | Talecris Biotherapeutics | Talecris Biotherapeutics | 2.6 | (includes Bayer Biologicals) CDC Changes made on: Feb. 28, 2006
UNK | Unknown manufacturer | Unknown manufacturer | 2.3 |
USA | United States Army Medical Research and Material Command | United States Army Medical Research and Material Command | 2.3.1 |
VXG | VaxGen | VaxGen | 2.6 | CDC Changes made on: July 14, 2006
WA | Wyeth-Ayerst | Wyeth-Ayerst | 2.3 | [Inactive--use WAL]
WAL | Wyeth-Ayerst | Wyeth-Ayerst | 2.3.1 | (includes Wyeth-Lederle Vaccines and Pediatrics, Wyeth Laboratories, Lederle Laboratories, and Praxis Biologics)
ZLB | ZLB Behring | ZLB Behring | 2.6 | (includes Aventis Behring and Armour Pharmaceutical Company) CDC Changes made on: Feb. 28, 2006